1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1055/s-0040-1718729
DC FieldValue
dc.titleThe East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
dc.contributor.authorKim, HK
dc.contributor.authorTantry, US
dc.contributor.authorSmith, SC
dc.contributor.authorJeong, MH
dc.contributor.authorPark, SJ
dc.contributor.authorKim, MH
dc.contributor.authorLim, DS
dc.contributor.authorShin, ES
dc.contributor.authorPark, DW
dc.contributor.authorHuo, Y
dc.contributor.authorChen, SL
dc.contributor.authorBo, Z
dc.contributor.authorGoto, S
dc.contributor.authorKimura, T
dc.contributor.authorYasuda, S
dc.contributor.authorChen, WJ
dc.contributor.authorChan, M
dc.contributor.authorAradi, D
dc.contributor.authorGeisler, T
dc.contributor.authorGorog, DA
dc.contributor.authorSibbing, D
dc.contributor.authorLip, GYH
dc.contributor.authorAngiolillo, DJ
dc.contributor.authorGurbel, PA
dc.contributor.authorJeong, YH
dc.date.accessioned2021-11-10T02:51:20Z
dc.date.available2021-11-10T02:51:20Z
dc.date.issued2021-04-01
dc.identifier.citationKim, HK, Tantry, US, Smith, SC, Jeong, MH, Park, SJ, Kim, MH, Lim, DS, Shin, ES, Park, DW, Huo, Y, Chen, SL, Bo, Z, Goto, S, Kimura, T, Yasuda, S, Chen, WJ, Chan, M, Aradi, D, Geisler, T, Gorog, DA, Sibbing, D, Lip, GYH, Angiolillo, DJ, Gurbel, PA, Jeong, YH (2021-04-01). The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. Thrombosis and Haemostasis 121 (4) : 422-432. ScholarBank@NUS Repository. https://doi.org/10.1055/s-0040-1718729
dc.identifier.issn03406245
dc.identifier.issn2567689X
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/205769
dc.description.abstractEast Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients.
dc.publisherGeorg Thieme Verlag KG
dc.sourceElements
dc.subjectrace
dc.subjectantiplatelet therapy
dc.subjectdirect oral anticoagulants
dc.subjectischemic risk
dc.subjectbleeding risk
dc.typeReview
dc.date.updated2021-11-09T03:25:53Z
dc.contributor.departmentMEDICINE
dc.description.doi10.1055/s-0040-1718729
dc.description.sourcetitleThrombosis and Haemostasis
dc.description.volume121
dc.description.issue4
dc.description.page422-432
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
The East Asian Paradox. An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.pdfPublished version456.18 kBAdobe PDF

CLOSED

Published

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.